These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3097413)

  • 1. Neonatal screening programme for congenital adrenal hyperplasia in a homogeneous Caucasian population.
    Cacciari E; Balsamo A; Cassio A; Piazzi S; Bernardi F; Salardi S; Cicognani A; Pirazzoli P; Zappulla F; Capelli M
    J Inherit Metab Dis; 1986; 9 Suppl 1():142-6. PubMed ID: 3097413
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatal screening program for congenital adrenal hyperplasia in a homogeneous Caucasian population.
    Cacciari E; Balsamo A; Cassio A; Piazzi S; Bernardi F; Salardi S; Cicognani A; Pirazzoli P; Zappulla F; Capelli M
    Ann N Y Acad Sci; 1985; 458():85-9. PubMed ID: 3879135
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal screening for congenital adrenal hyperplasia.
    Cacciari E; Balsamo A; Cassio A; Piazzi S; Bernardi F; Salardi S; Cicognani A; Pirazzoli P; Zappulla F; Capelli M
    Arch Dis Child; 1983 Oct; 58(10):803-6. PubMed ID: 6639129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia].
    Fukushi M; Arai O; Mizushima Y; Takasugi N; Fujieda K; Matsuura N
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):683-96. PubMed ID: 3530828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experience of neonatal screening for congenital adrenal hyperplasia.
    Cicognani A
    Horm Res; 1992; 37 Suppl 3():34-8. PubMed ID: 1427639
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal screening for congenital adrenal hyperplasia: a pilot study in France.
    Dhondt JL; Dorche C; Farriaux JP; Courte C
    J Inherit Metab Dis; 1986; 9 Suppl 1():147-51. PubMed ID: 3097414
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots.
    Larsson A; Hagenfeldt L; von Döbeln U; Curstedt T; Gustafsson J; Svensson E
    Horm Res; 1988; 30(6):235-40. PubMed ID: 3250925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neonatal mass-screening for congenital adrenal hyperplasia in Japan.
    Shimozawa K; Saisho S; Saito N; Yata J; Igarashi Y; Hikita Y; Irie M; Okada K
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):513-8. PubMed ID: 6516697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of selective screening for congenital adrenal hyperplasia in Hungary.
    Sólyom J; Hughes IA
    Arch Dis Child; 1989 Mar; 64(3):338-42. PubMed ID: 2705794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY; Wallace MA; Hofman L; Thuline HC; Dorche C; Lyon IC; Dobbins RH; Kling S; Fujieda K; Suwa S
    Pediatrics; 1988 Jun; 81(6):866-74. PubMed ID: 3259306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens.
    Thompson R; Seargeant L; Winter JS
    J Pediatr; 1989 Mar; 114(3):400-4. PubMed ID: 2784166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening for congenital adrenal hyperplasia in Japan.
    Naruse H; Suzuki E; Irie M; Tsuji A; Takasugi N; Fukushi M; Matsuura N; Shimozawa K
    Ann N Y Acad Sci; 1985; 458():103-10. PubMed ID: 3911846
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorescence enzyme immunoassay of 17 alpha-hydroxyprogesterone in dried blood samples on filter paper and its application to mass screening for congenital adrenal hyperplasia.
    Arakawa H; Maeda M; Tsuji A; Naruse H; Suzuki E; Kambegawa A
    Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2724-31. PubMed ID: 6360394
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of adrenal 21-hydroxylase deficiency in neonates born in the West Midlands: a retrospective study.
    Rudd BT
    J Inherit Metab Dis; 1986; 9 Suppl 1():155-6. PubMed ID: 3097416
    [No Abstract]   [Full Text] [Related]  

  • 15. [17-hydroxyprogesterone in blood dried on filter paper from healthy premature and term neonates and patients with congenital adrenal hyperplasia].
    Zurga B; Dumić M; Plavsić V; Mardesić D; Vondracek M; Stefanović N
    Lijec Vjesn; 1988 May; 110(5):136-40. PubMed ID: 3412101
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
    Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of CAH screening programmes and the Scottish experience.
    Wallace AM
    J Inherit Metab Dis; 1986; 9 Suppl 1():135-41. PubMed ID: 3097412
    [No Abstract]   [Full Text] [Related]  

  • 18. How reliable is newborn screening for congenital adrenal hyperplasia?
    Pass KA
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):74-5. PubMed ID: 16932259
    [No Abstract]   [Full Text] [Related]  

  • 19. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J
    Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska.
    Pang S; Spence DA; New MI
    Ann N Y Acad Sci; 1985; 458():90-102. PubMed ID: 3879136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.